Social and Behavioral Influence (SBI)
The purpose of the study is to improve patient-physician communication and clinical decisions in the context of serious illness that may affect important clinical outcomes. The investigators will examine how variations in communication patterns and clinical decisions are affected by patient demographics (e.g age, sex), patient interactional style (e.g. communication behaviors) and physician characteristics (e.g. attitudes, background, training).
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Social and Behavioral Influences|
- Physicians' Communication Style [ Time Frame: 2 years ] [ Designated as safety issue: No ]To examine the degree to which physicians communication style (ex inclusive, authoritative) and clinical decisions (ex. aggressive,passive) differ according to patient characteristics. Unit of Measure: Audio recordings of office visits, will be transcribed, deidentified, and coded.
- Physician Communication Moderators (Sex,Class) [ Time Frame: 2 years ] [ Designated as safety issue: No ]To examine how patients participating in their care reduces these patient-specific differences in physician communication behaviors and decisions. Unit of Measure: Audio recordings of office visits, will be transcribed, deidentified, and coded.
|Study Start Date:||October 2010|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
Physician communication styles will be evaluated with different patient roles.
This will be a randomized field experiment. Physicians will receive two unannounced covert standardized patient (SP) visits during the 12-24 months after enrollment. SPs are trained actors who will pose as patients to assess physician behavior and communication. Each SP will present just like a real patient, and will have a standardized fabricated scenario and identity. The SP visit will be unannounced; the physician will not be informed at the time of the visit that they are seeing an SP. The visits will be covertly audio-recorded. This is being conducted at 3 sites: University of Rochester, Rochester, NY; Purdue, IN; and University of Michigan.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01501006
|United States, New York|
|University Of Rochester|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Ronald Epstein, MD||University of Rochester|